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SUMMARY
The gene expression programs that define each cell’s identity are controlled by master 
transcription factors (TFs) that bind cell-type specific enhancers, as well as signaling factors, 
which bring extracellular stimuli to these enhancers. Recent studies have revealed that master TFs 
form phase-separated condensates with the Mediator coactivator at super-enhancers. Here we 
present evidence that signaling factors for the WNT, TGF-β and JAK/STAT pathways employ their 
intrinsically disordered regions (IDRs) to enter and concentrate in Mediator condensates at super-
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enhancers. We show that the WNT coactivator β-catenin interacts both with components of 
condensates and DNA binding factors to selectively occupy super-enhancer associated genes. We 
propose that the cell-type specificity of the response to signaling is mediated, in part, by the IDRs 
of the signaling factors, which cause these factors to partition into condensates established by the 
master TFs and Mediator at genes with prominent roles in cell identity.
Graphical Abstract
eTOC
Zamudio et al. demonstrate that components of the WNT, TGF-β and JAK/STAT signaling 
pathways employ their intrinscially disordered regions to condense with Mediator and to target 
specific genes. These findings provide a model for how context-dependent transcriptional 
responses can be achieved in cell signaling.
INTRODUCTION
Pioneering genetic studies in Drosophila showed that transcription factors and signaling 
factors play fundamentally important roles in the control of development (Nüsslein-Volhard 
and Wieschaus, 1980; Small et al., 1992; van de Wetering et al., 1997; Yan et al., 1996). 
These and many subsequent studies have led to the understanding that the gene expression 
programs defining each cell’s identity are controlled by lineage and cell-type specific master 
TFs, which establish cell-type specific enhancers, and signaling factors, which carry 
extracellular information to these enhancers (David and Massagué, 2018; Lee and Young, 
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2013; Mullen and Wrana, 2017; Nusse and Clevers, 2017; Rawlings, 2004). Hundreds of 
different master TFs contribute to the diverse cell-type specific gene expression programs in 
an animal, yet a small set of common signaling factors are utilized to produce cell-type 
specific responses to extracellular stimuli. How this is accomplished is not fully understood.
The results of transdifferentiation and reprogramming experiments argue that a small 
number of master TFs dominate the control of cell-type specific gene expression (Takahashi 
and Yamanaka, 2016; Theunissen and Jaenisch, 2014). Although many hundreds of TFs are 
expressed in each cell type, only a handful are necessary to cause cells to acquire a new 
identity, as demonstrated by the ability of the TF MyoD to transdifferentiate cells into 
muscle-like cells (Weintraub et al., 1989), and the ability of the TFs Oct4, Nanog, Klf4 and 
Myc to reprogram fibroblasts into induced pluripotent stem cells (Takahashi et al., 2006). 
These master TFs dominate the control of gene expression programs by establishing 
enhancers, and often clusters of enhancers called super-enhancers, at genes with prominent 
roles in cell identity (Hnisz et al., 2013; Lee and Young, 2013; Whyte et al., 2013).
Cells depend on signaling pathways to maintain their identity and to respond to the 
extracellular environment. The signaling pathways that play prominent roles in control of 
mammalian developmental processes include the WNT, TGF-β and JAK/STAT pathways 
(David and Massagué, 2018; Nusse and Clevers, 2017; Rawlings, 2004). The terminal 
signaling factors of the WNT, JAK/STAT and TGF-β pathways are β-catenin, STAT3 and 
SMAD3, respectively. In each of these pathways, an extracellular ligand is recognized by a 
specific receptor, which transduces the signal through other proteins to a set of signaling 
factors that enter the nucleus and occupy signal response elements in the genome. They do 
this either through interaction with other TFs (the case for β-catenin) or through their own 
DNA-binding activities (STAT3 and SMAD3) (Darnell et al., 1994; Molenaar et al., 1996; 
Yingling et al., 1997). In a given cell type, these signaling factors interact with a small 
subset of a large number of putative signal response elements, preferring to occupy those 
that occur in the active enhancers of that cell type. This allows for cell type-specific 
responses to a common set of signaling factors that are expressed in a broad spectrum of cell 
types (David and Massagué, 2018; Hnisz et al., 2015; Mullen et al., 2011; Trompouki et al., 
2011).
Several mechanisms have been described to account for the ability of signaling factors to 
preferentially bind the cell-type specific enhancers and super-enhancers of any one cell type. 
The WNT signaling factor β-catenin does not have its own DNA binding domain and is 
thought to be recruited to genes through interaction with TCF/LEF TFs. The SMAD 
signaling factors can bind with weak affinity to a short DNA motif that is present at high 
frequency in the mammalian genome, whereas the STAT proteins have relatively long and 
specific DNA motifs (Farley et al., 2015). The preferred binding by all three signaling 
factors to active enhancers may reflect, in part, preferred access of these TFs to the “open 
chromatin” associated with active enhancers (Mullen et al., 2011). These signaling factors 
may also prefer to bind such sites due to structural changes in the DNA mediated by binding 
of other TFs at these enhancers (Hallikas et al., 2006; Zhu et al., 2018) or bind cooperatively 
through direct protein-protein interactions with master TFs (Kelly et al., 2011). These 
Zamudio et al. Page 3
Mol Cell. Author manuscript; available in PMC 2020 December 05.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
models, however, may not fully explain how a single signaling factor like β-catenin manages 
to interact with the cell-type specific enhancers formed by hundreds of different master TFs.
Recent studies have revealed that master TFs and the Mediator coactivator form phase-
separated condensates at super-enhancers, which compartmentalize and concentrate the 
transcription apparatus at key cell identity genes (Boija et al., 2018; Cho et al., 2018; Sabari 
et al., 2018). Signaling factors have been shown to have a special preference for cell type-
specific super-enhancers (Hnisz et al., 2015), leading us to postulate that signaling factors 
might have properties that lead them to partition into transcriptional condensates at super-
enhancers, a previously uncharacterized mechanism for cell type-specific enhancer 
association. Here we report that signaling factors are incorporated into condensates with 
coactivators in response to signaling stimuli at super-enhancer driven genes in a cell type-
specific fashion. Indeed, β-catenin is incorporated into Mediator condensates even when it 
lacks the domain responsible for interaction with TCF/LEF factors. Optimal occupancy of 
super-enhancer loci is thus obtained by β-catenin when it contains both condensate-
interaction and TF-interaction domains. We propose that phase separation helps achieve the 
context-dependent specificity of signaling by concentrating signaling factors in master TF-
driven transcriptional condensates.
RESULTS
Signal-dependent incorporation of signaling factors into condensates at super-enhancers
Recent studies have shown that TFs and Mediator form phase-separated condensates at 
super-enhancers (Boija et al., 2018; Cho et al., 2018; Sabari et al., 2018) and the terminal 
signaling factors of the WNT, JAK/STAT and TGF-β pathways (β-catenin, STAT3 and 
SMAD3, respectively) have been shown to preferentially occupy super-enhancers (Hnisz et 
al., 2015). To test whether these signaling factors are incorporated into condensates at super-
enhancer associated genes, we performed RNA FISH for Nanog in combination with 
immunofluorescence for each of the three signaling factors (Figure 1A). Nanog, a gene 
important for pluripotency, is associated with a super-enhancer occupied by these three 
signaling factors and Mediator in mouse embryonic stem cells (mESCs) as shown by ChIP-
sequencing (Figure 1B). We found that condensed foci could be observed for all three 
factors at the Nanog locus in individual cells (Figure 1A), suggesting that all three factors 
are incorporated into super-enhancer associated condensates. Similar results were obtained 
at an additional super-enhancer locus where transcriptional condensates have been 
demonstrated to occur in mESCs (Boija et al, 2018; Sabari et al., 2018) (Figure S1A, B). To 
confirm that the association of signaling factors with this locus is cell type-specific, we 
investigated whether β-catenin condensed foci overlapped with Nanog in C2C12 myoblast 
cells using a combination of immunofluorescence and DNA FISH; no β-catenin signal was 
detected at this locus in C2C12 cells (Figure S1C). These results are consistent with the idea 
that signaling factors are incorporated into cell type-specific super-enhancer condensates.
To confirm that the β-catenin, STAT3 and SMAD3 signaling factors are incorporated into 
nuclear condensates upon pathway stimulation, we performed immunofluorescence for those 
factors in mESCs in the presence or absence of the stimulus for each signaling pathway. We 
found that all three signaling factors were detected as condensed nuclear foci by 
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immunofluorescence when their respective signaling pathways were activated (Figure 1C). 
These results indicate that β-catenin, SMAD3 and STAT3 are incorporated into nuclear 
condensates upon pathway activation.
The condensates formed by transcription factors and Mediator at super-enhancers exhibit 
liquid-like behavior (Boija et al., 2018; Cho et al., 2018; Sabari et al., 2018). A hallmark of 
liquid-liquid phase-separated condensates is dynamic internal re-organization and rapid 
exchange kinetics (Banani et al., 2017; Hyman et al., 2014; Shin and Brangwynne, 2017), 
which can be interrogated by measuring the rate of fluorescence recovery after 
photobleaching (FRAP). To test whether signaling factors exhibit this type of behavior, we 
introduced a mEGFP-tag at the endogenous locus of the β-catenin gene in constitutive 
WNT-activated HCT116 cells, confirmed that the levels of mEGFP-tagged β-catenin 
expressed in these cells were similar to those normally expressed in these cells (Figure 
S1D), and examined the behavior of these condensates by FRAP. The β-catenin nuclear 
puncta recovered on a time-scale of seconds (Figure 1D), with an approximate apparent 
diffusion coefficient of 0.004 ± 0.003 µm2/s. These values are similar to those of previously 
described components of liquid-like condensates, including euchromatic (Nott et al., 2015; 
Pak et al., 2016, Sabari et al., 2018) and heterochromatic condensates (Figure 1D, S1D) 
(Strom et al. 2017; Larson et al. 2017; Zhang et al. 2019), and support the idea that 
condensates containing β-catenin exhibit liquid-like properties. Taken together with previous 
evidence for liquid-like condensates at super-enhancers, which include rapid exchange 
kinetics and fusion events between condensate components (Cho et al., 2018; Sabari et al., 
2018), these results suggest that β-catenin is incorporated and concentrated into these 
transcriptional condensates.
To investigate the dynamics of β-catenin-containing puncta in response to WNT pathway 
stimulation, we used HEK293T cells containing a mEGFP tag at the endogenous β-catenin 
locus, stimulated these cells with a WNT activator, and followed the appearance of nuclear 
β-catenin puncta in live cells over time. We observed a steady increase in β-catenin-
containing nuclear foci for approximately 4 hours following stimulation (Figure 1E). These 
results indicate that β-catenin becomes a component of nuclear condensates in live cells in a 
WNT-inducible manner.
Purified signaling factors can form condensates in vitro
An analysis of the amino acid sequences of β-catenin, STAT3 and SMAD3 revealed that 
they contain intrinsically disordered regions (IDRs) (Figure 2A, S2). Because IDRs are 
capable of forming dynamic networks of weak interactions and have been implicated in 
condensate formation (Burke et al., 2015; Lin et al., 2015; Nott et al., 2015), we investigated 
whether these signaling proteins could form phase-separated droplets in vitro. Indeed, 
purified recombinant mEGFP-β-catenin, mEGFP-STAT3 and mEGFP-SMAD3, formed 
concentration-dependent droplets (Figure 2B). The droplets were spherical, micron-sized 
and freely moved in solution. The droplet forming behavior of these proteins exhibited a 
switch in partition ratio between the dense and dilute phases at micromolar concentrations, 
consistent with behavior of proteins that undergo phase separation (Figure 2B). Further 
characterization of these droplets revealed that they were reversible by dilution and sensitive 
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to salt concentration (Figure 2C). The droplets exhibited rapid recovery kinetics after 
photobleaching (Figure 2D). To determine whether the signaling proteins were able to form 
droplets in the absence of crowding agents, we expressed mEGFP-tagged forms of the 
signaling factors in HEK293T cells, created nuclear extracts from these cells, and imaged 
these extracts. Using this assay we found that all three signaling factors formed droplets in 
the absence of crowding agents (Figure 2E). We also generated a phase diagram for each of 
the signaling factors by varying the salt and protein concentrations in the assay, showing that 
either one phase (dilute) or two phases (dilute and condensed) could be observed at different 
regimes of the diagram (Figure 2F). These data are consistent with the model that these 
signaling factors are capable of undergoing liquid-liquid phase separation in vitro.
Purified signaling factors are incorporated into Mediator condensates in vitro
The transcriptional condensates formed at super-enhancers contain high concentrations of 
the Mediator coactivator, and transcription factors interact with Mediator through the same 
residues that are important for phase separation of their activation domains (Sabari et al., 
2018; Boija et al., 2018). Given the droplet forming properties of β-catenin, SMAD3 and 
STAT3 and their localization in vivo, we reasoned that these signaling proteins might also 
interact with, and be concentrated into, Mediator condensates. To test this idea we used 
MED1-IDR, a surrogate for Mediator complex (Boija et al., 2018), to form droplets in 
PEG-8000, added dilute signaling factors to the solution, and monitored the incorporation of 
signaling factors into MED1-IDR droplets (Figure 3A). We found that β-catenin, SMAD3 
and STAT3 were incorporated and concentrated in MED1-IDR droplets (Figure 3B, C, 
Supplemental Videos 1–3). To verify that the signaling factors are also capable of interacting 
with the full Mediator complex in these droplet assays, droplets were formed with the three 
signaling factors in combination with purified Mediator complex (Meyer et al., 2008). All 
three signaling factors, but not mEGFP alone, were able to concentrate into Mediator 
complex droplets (Figure 3D).
β-catenin, SMAD3 and STAT3 are found at nanomolar concentrations in mammalian cells 
(Beck et al., 2017), but the concentrations at which the recombinant signaling proteins form 
droplets in vitro are in the micromolar range (Figure 2B). This led us to investigate if 
signaling factors can form droplets at nanomolar concentrations in the presence of MED1-
IDR, where they do not form detectable droplets of their own. In these assays, the signaling 
factors were efficiently partitioned into MED1-IDR droplets, even when the levels of 
MED1-IDR were reduced to nanomolar concentrations (Figure 3E, S3A). These results are 
consistent with the possibility that partitioning of signaling factors into Mediator 
condensates contributes to the localization of signaling factors to transcriptional condensates 
at super-enhancers.
Phase separation of β-catenin and activation of target genes are dependent on intrinsically 
disordered regions
If the enrichment of signaling factors at super-enhancers occurs through the phase separation 
properties of their IDRs and incorporation into Mediator condensates, then mutations in the 
IDRs that affect their ability to form phase-separated droplets in vitro would be expected to 
affect their ability to target and activate genes in vivo. To test this hypothesis, we focused 
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further studies on β-catenin and sought to identify portions of the protein responsible for its 
phase separation properties. β-catenin consists of a central, structured domain with 
Armadillo repeats surrounded by an N-terminal IDR and a C-terminal IDR (Figure 4A). 
Droplet assays showed that recombinant proteins containing only the Armadillo repeats or 
the N-terminal or C-terminal IDRs were not capable of phase separating at any of the 
concentrations tested (Figure 4A), suggesting that a combination of multiple domains may 
be required for condensate formation. To test if the combination of N-terminal and C-
terminal IDRs are sufficient to form phase-separated droplets, a chimeric β-catenin protein 
was generated in which the central armadillo repeats were replaced by a copy of mEGFP 
(Figure 4A). When tested in a droplet assay, the chimera protein with both N- and C-
terminal IDRs was able to form droplets, albeit slightly smaller and with a lower partion 
coefficient than the full length β-catenin (Figure 4A, S4A). If the β-catenin IDRs contribute 
to phase separation, then condensate formation might be enhanced by doubling their size, 
which should increase the valence of interactions (Alberti, Gladfelter, and Mittag, 2019). To 
test this possibility, we engineered and purified a mutant β-catenin protein containing an 
extra copy of each IDR. This 2x IDR protein readily formed droplets that were substantially 
larger than those formed by full length β-catenin (Figure 4A, S4A). Taken together, these 
data suggest that the IDRs of β-catenin are necessary and sufficient for formation of phase-
separated condensates in vitro.
We next focused attention on the amino acid residues within the two IDRs that might 
contribute to condensation, and noted an abundance of aromatic residues (Figure S2). We 
generated a mutant form of β-catenin and of the chimera protein where the aromatic residues 
in both IDRs were substituted with alanines (Figure 4A). These types of mutations perturb 
pi-cation interactions, which play an important role in the phase separation capacity of 
multiple proteins (Frey et al., 2018; Wang et al., 2018). When tested in a droplet formation 
assay, neither the mutant form of β-catenin, nor the mutant chimera protein were able to 
form droplets (Figure 4A, S4A). When tested in a heterotypic droplet formation assay with 
MED1-IDR, the mutant β-catenin protein failed to incorporate and concentrate into MED1-
IDR droplets (Figure 4B, C). The mutant form of β-catenin also failed to incorporate into 
full Mediator droplets (Figure S4B). These results suggest that the aromatic residues in the 
IDRs of β-catenin contribute to its phase separation behavior.
To test whether the IDRs contribute to β-catenin’s function in vivo, constructs encoding 
TdTomato-tagged wild type, and the aromatic mutant form of β-catenin, under control of a 
doxycycline-inducible promoter, were integrated into the genome of mESCs (Figure 5A, 
S5A,C) and ChIP-qPCR for tagged-β-catenin was performed after activation by 
doxycycline. Wild type β-catenin was found to occupy the WNT-responsive super-enhancer 
associated genes Sp5, Klf4 and Myc, as expected, while lower levels of the aromatic mutant 
were found at these enhancers using this exogenous expression system (Figure 5B). 
Expression of these genes was also lower in conditions where mutant β-catenin was 
expressed compared to those where wild type β-catenin was expressed (Figure 5C). Neither 
wild-type nor mutant β-catenin factors were found to occupy the typical enhancers of Actrt2 
and Fam186b (Figure S5B). Imaging of these exogenous proteins in live cells revealed that 
the ability of the mutant form of β-catenin to condense was reduced compared to wild-type 
(Figure S5C). These results suggest the IDRs of β-catenin are necessary for both condensate 
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formation and for β-catenin’s proper association and function at super-enhancers in cells that 
express exogenous β-catenin.
We independently tested the ability of the β-catenin aromatic mutant to transactivate a WNT-
responsive reporter gene in a luciferase assay (Figure 5D). Exogenous expression of wild 
type β-catenin stimulated luciferase activity, whereas exogenous expression of the aromatic 
mutant stimulated significantly less activity (Figure 5D). Neither of these forms of β-catenin 
induced expression of a WNT-insensitive reporter (Figure S5D). These results are consistent 
with a model in which β-catenin amino acids necessary for condensate formation with 
Mediator in vitro are also important for gene activation in vivo.
β-catenin-condensate interaction can occur independently of TCF factors
β-catenin does not have DNA-binding activity and the conventional model for β-catenin 
recruitment to genes involves a structured interaction between its Armadillo repeats and a 
TCF/LEF family DNA-binding transcription factor. If β-catenin can be recruited to Mediator 
condensates through dynamic interactions that allow β-catenin to be incorporated into 
condensates in vivo, then this should occur in the absence of TCF/LEF factors. We 
developed a series of assays to test this idea.
We first investigated whether β-catenin could be incorporated into MED1 condensates in 
vivo by using a previously developed lac-array assay (Janicki et al., 2004) (Figure 6A). The 
MED1-IDR was tethered to an array of LacI binding sites in U2OS cells, which have a 
constitutively activated WNT signaling pathway (Chen et al., 2015) and thus have detectable 
levels of β-catenin in the nucleus. Cells were transiently transfected with either LacI-MED1-
IDR or control LacI. The LacI-MED1-IDR, but not LacI alone, was found to recruit 
endogenous β-catenin to the lac array (Figure 6A). This effect was likely not mediated 
through interactions with TCF/LEF and direct interaction with DNA because the lac array 
does not contain TCF motifs and no TCF/LEF family member was detected at LacI-MED1-
IDR foci by IF (Figure S6A). The heterochromatin binding protein HP1α served as a control 
and was also not recruited to the array (Figure S6B). When TdTomato-labeled wild type and 
aromatic mutant β-catenin were ectopically expressed, the TdTomato-labeled wild type β-
catenin accumulated at the MED1-IDR occupied lac array, while accumulation of the 
TdTomato-labeled aromatic mutant was significantly reduced (Figure 6B). Additionally, 
when transcription of CFP from the lac-array locus was assayed by RT-qPCR, the wild type 
β-catenin induced significantly stronger expression than the mutant β-catenin (Figure S6G). 
The β-catenin aromatic mutant maintained its ability to interact with TCF/LEF factors based 
on a co-immunoprecipitation assay with TCF7L2 in HEK293T cells (Figure S6C). These 
results suggest that β-catenin can be incorporated into MED1-IDR condensates in vivo in 
the absence of TCF/LEF family members and in a manner that is dependent on the same 
amino acids that are required for β-catenin to be incorporated and concentrated into 
Mediator condensates in vitro.
To further test if the regions of β-catenin that allow it to be incorporated into a condensate 
with with Mediator are sufficient to address β-catenin to specific genomic loci in the 
absence of an interaction with TCF/LEF factors, we engineered a HEK293T cell line in 
which β-catenin, the β-catenin-chimera or the β-catenin-chimera mutant was integrated 
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under the control of a doxycycline inducible promoter (Figure S6E). ChIP-qPCR for GFP 
showed enrichment for wild type β-catenin and β-catenin-chimera, but not the aromatic 
mutant chimera, at the WNT-driven super-enhancer genes SOX9, SMAD7 and KLF9 
(Figure 6C). Two typical-enhancers showed no enrichment for any of the tagged factors, 
indicating that the IDRs of β-catenin are sufficient to address mEGFP to specific genomic 
loci (Figure S6D). This effect was not due to differences in expression of these factors as the 
chimera and mutant chimera expressed at comparable levels as the wild type form of β-
catenin (Figure S6E). The C-terminal IDR of β-catenin contains its transactivation domain, 
so we sought to investigate if the β-catenin-chimera might also be able to activate 
transcription as well as localize to the correct genomic locations. When the β-catenin-
chimera was over-expressed in a luciferase reporter assay, it was able to activate a WNT-
reporter (Figure 6D). None of these forms of β-catenin were able to robustly activate 
expression of a WNT unresponsive reporter (Figure S6F). These data are consistent with the 
idea that β-catenin can be recruited to a Mediator condensate, at least partially, through its 
ability to interact with this condensate and independently of its classical interaction with 
TCF/LEF factors.
Both intrinsically disorderded and Armadillo domains enable selective occupancy of 
super-enhancer genes
Our evidence, together with that of prior studies on the structured armadillo domain 
(Behrens et al., 1996, Molenaar et al., 1996, van de Wetering et al., 1997), suggest that β-
catenin interacts with super-enhancers through both the condensate interaction properties of 
its IDRs and the TF interaction properties of the Armadillo repeat domain. A prediction of 
this model is that full length β-catenin, the IDR chimera alone, and the armadillo repeat 
alone may all have the ability to be incorporated into super-enhancer loci in cells. To test this 
prediction, we engineered endogenously-tagged mEGFP-β-catenin mES cells and mES cells 
expressing integrated mEGFP-tagged-armadillo-repeats (armadillo) or mEGFP-tagged-IDRs 
(chimera) under the control of a dox-inducible promoter (Figure 7A, S7A). The mES cells 
express the TCF/LEF factor TCF3, which we have previously shown occupies enhancers 
with master transcription factors, and thus provides a DNA-anchoring interaction with β-
catenin (Hnisz et al., 2015). An anti-GFP antibody was used to conduct ChIP-sequencing in 
all three cell lines, and the results revealed that both the armadillo repeat protein and the 
chimeric IDR protein are similarly associated with super-enhancers (Figure 7B, 7C, S7B). 
The full length β-catenin protein produced higher signal than either of the proteins 
consisting of its components (Figure 7B, 7C), consistent with the notion that both IDR and 
armadillo-repeat components have roles in localizing to super-enhancers. These results are 
consistent with the model that both the condensate interaction properties of β-catenin’s IDRs 
and the structured TF interaction properties of its armadillo repeat domain contribute to 
selective occupancy at super-enhancers.
DISCUSSION
Diverse cell types employ a small set of shared, developmentally-important signaling 
pathways to transmit extracellular information to modify gene expression programs 
(Perrimon et al., 2012). In any one cell type, effector components of the WNT, TGF-β and 
Zamudio et al. Page 9
Mol Cell. Author manuscript; available in PMC 2020 December 05.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
JAK/STAT pathways connect to only a small subset of a large number of potential signal 
response elements, preferring to bind those in active enhancers formed by the master 
transcription factors of that cell type, thus producing cell type-specific responses (David and 
Massagué, 2018; Hnisz et al., 2015; Mullen et al., 2011; Trompouki et al., 2011). The 
mechanisms that have been described to account for this bias include preferential access to 
“open chromatin” (Mullen et al, 2011), to altered DNA structures caused by binding of other 
TFs, and cooperative protein-protein interactions with master TFs (Hallikas et al., 2006; 
Kelly et al., 2011). The observation that signaling factors have a special preference for cell 
type-specific super-enhancers (Hnisz et al., 2015), coupled with the finding that TFs and 
Mediator form phase-separated condensates at super-enhancers (Boija et al., 2018; Cho et 
al., 2018; Sabari et al., 2018), led us to investigate whether signaling factors have properties 
that facilitate partitioning into transcriptional condensates at super-enhancers. The evidence 
described here argues that the cell type-dependent specificity of signaling may be achieved, 
at least in part, by addressing signaling factors to transcriptional condensates at super-
enhancers. In this manner, the specificity of the response to signaling can be achieved 
through the combination of signaling factor incorporation into the condensate compartment 
and through interaction with DNA or DNA-binding factors.
We find that the signaling factors β-catenin, STAT3 and SMAD3 occur in condensed puncta 
at signal-responsive super-enhancers in ESCs, where transcriptional condensates have been 
reported to contain hundreds of molecules of Mediator and RNA polymerase II (Boija et al., 
2018; Cho et al., 2018; Sabari et al., 2018). These signaling factors can be incorporated and 
concentrated into Mediator condensates in vitro, suggesting that their ability to enter 
Mediator condensates might contribute to their preferential association with Mediator 
condensates found at super-enhancers in vivo. Indeed, tethering a Mediator subunit to an 
array of genomic sites forms a condensate that can recruit at least one of these signaling 
factors, β-catenin, to the condensate and does so in the absence of a structured interaction 
with its classic partner, the DNA-binding factor TCF7L2. In addition, we find that the β-
catenin IDRs alone, and the transcription factor binding armadillo repeat alone, can be 
recruited to super-enhancer loci genome-wide; optimal recruitment requires both 
intrinsically disordered and Armadillo domains.
Condensate formation at super-enhancers provides a compartment to concentrate the 
transcription apparatus at highly expressed genes that play prominent roles in cell identity 
(Boija et al., 2018; Cho et al., 2018; Sabari et al., 2018). The results described here indicate 
that these condensates can also compartmentalize signaling factors, which helps explain why 
signaling factors are preferentially recruited to super-enhancer loci (Hnisz et al., 2015). In 
the absence of the ability to interact with DNA or a DNA-binding factor, the signaling 
factors are free to exit the condensate, so we suggest that it is the combination of 
condensate-mediated concentration of signaling factors and DNA binding that provides the 
exquisite specificity and high level of gene activation characteristic of this signaling.
The model we describe for β-catenin entry into super-enhancer condensates may help 
explain additional conundrums in the signaling literature. For example, β-catenin has been 
reported to interact with a large number of different proteins (Schuijers et al., 2014) and this 
interaction promiscuity has resulted in the proposal that a large number of DNA-binding 
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transcription factors have the capacity to recruit β-catenin in addition to the canonical 
recruiters of the TCF/LEF family (Nateri et al., 2005; Kouzmenko et al, 2004; Essers et al., 
2005; Kaidi et al., 2007; Botrugno et al., 2004; Kelly et al., 2011; Sinner et al., 2004). 
However, the majority of these reported interactions were not supported by functional data 
and only binding to TCF has been supported by co-crystallization (Poy et al., 2001; 
Sampietro et al., 2006). Our model might explain how β-catenin could functionally interact 
with a large number of TFs in a transcriptional condensate, yet fail to activate transcription 
in an artificial system where such a condensate might not be assembled.
The condensate model described here may also apply to additional signaling pathways such 
as those of the Notch, Hedgehog and receptor tyrosine kinase pathways. The condensate 
model may also facilitate further understanding of pathological signaling in diseases such as 
cancer. Dysregulated transcription and signaling are in fact two hallmarks of cancer 
(Bradner et al., 2017). Cancer cells develop genomic alterations that create super-enhancers 
at driver oncogenes (Chapuy et al., 2013; Hnisz et al., 2013; Lin et al., 2016; Mansour et al., 
2014; Zhang et al., 2016), and these oncogenes are especially responsive to oncogenic 
signaling (Hnisz et al., 2015). The signaling factors that contribute to oncogenic signaling 
may generally interact with super-enhancer condensates through properties that also promote 
phase separation. In this way, tumor cells dependent on a particular signaling pathway could 
acquire resistance to therapies by employing alternative signaling pathways whose signaling 
factors could incorporate into transcriptional condensates. Perhaps therapies that target both 
oncogenic signaling pathways and super-enhancer components will prove especially 
effective in tumor cells that have signaling and transcriptional dependencies.
STAR METHODS
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Richard A. Young (young@wi.mit.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines—V6.5 murine embryonic stem cells were a gift from Jaenisch lab. HEK293T 
and HCT116 cells were obtained from ATCC. U2OS cells were obtained from the Spector 
lab. Cells were routinely tested for mycoplasm.
Cell culture conditions—V6.5 murine embryonic stem cells were grown on 2i + LIF 
conditions on 0.2% gelatinized (Sigma, G1890) tissue culture plates. The media used for 2i 
+ LIF media conditions is as follows: 967.5 mL DMEM/F12 (GIBCO 11320), 5 mL N2 
supplement (GIBCO 17502048), 10 mL B27 supplement (GIBCO 17504044), 0.5 mM L-
glutamine (GIBCO 25030), 0.5X non-essential amino acids (GIBCO 11140), 100 U/mL 
Penicillin-Streptomycin (GIBCO 15140), 0.1 mM β-mercaptoethanol (Sigma), 1 uM 
PD0325901 (Stemgent 04–0006), 3 uM CHIR99021 (Stemgent 04–0004), and 1000 U/mL 
recombinant LIF (ESGRO ESG1107). HEK293T, U2OS and HCT116 cells were cultured in 
DMEM, high glucose, pyruvate (GIBCO 11995–073) with 10% fetal bovine serum 
(Hyclone, characterized SH3007103), 100 U/mL Penicillin-Streptomycin (GIBCO 15140), 2 
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mM L-glutamine (Invitrogen, 25030–081). Sf9 cells were cultured in Sf-900 III SFM 
(GIBCO 12658–019) supplemented with 0.017mg/ml of penecilin streptomycin (GIBCO 
15140).
Cell line stimulation—For WNT: Cells were treated with either CHIR99021 or IWP2 
(Sigma Aldrich I0536) for 24hrs in 2i + LIF medium without CHIR (mES) or with CHIR in 
10% FBS DMEM medium (HEK293). For SMAD3: Cells were treated with ActivinA 
(R&D systems 338-AC-010) or SB431542 (Tocis Bioscience 16–141) for 24 hours in 2i + 
LIF medium. For STAT3: Cells were treated with 2i + LIF or 2i - LIF medium for 24 hours
Cell line generation—V6.5 murine embryonic stem cells, HCT116 colorectal cancer cells 
or HEK293T embryonic kidney cells were genetically modified using the CRISPR-Cas9 
system. A guide targeting the N-terminus of beta catenin was cloned into a px330 vector 
with an mCherry selectable marker and the following sequence: 
CTGCGTGGACAATGGCTACT. A repair template with 800 bp homology to the 
endogenous locus flanking an mEGFP-tag was cloned into a pUC19 vector. Cells were 
transfected with 2.5 µg of both constructs and sorted for mCherry two days post-transfection 
and sorted again for mEGFP one week post-transfection. Cells were serially diluted and 
colonies were picked to obtain clonal cell lines.
METHOD DETAILS
FRAP—FRAP was performed on LSM880 Airyscan microscope with 488nm laser. 
Bleaching was performed over a rbleach ≈ 1 um using 100% laser power and images were 
collected every two seconds.
Immunofluorescence: Cells were fixed in 4% paraformaldehyde for 10 mins at RT as 
described in Sabari et al. 2018. Cells were then washed three times and permeabilized with 
0.5 TritonX 100 in PBS for 5 min at RT. Following three washes in PBS cells were blocked 
in 4% Bovine Serum Albumin for 15 mins at RT and incubated with primary antibodies in 
4% BSA overnight at room temperature. After three washes in PBS, cells were incubated in 
secondary antibodies in 4% BSA in the dark for 1 hour. Cells were washed three times with 
PBS followed by an incubation with Hoechst for 5 mins at RT in the dark. Slides were 
mounted with Vectashield H-1000 and coverslips were sealed with transparent nail polish 
and stored at 4C. Images were acquired using an RPI Spinning Disk confocal microscope 
with a 100x objective using a Metamorph software and a CCD camera.
Co-Immunofluorescence with DNA FISH: Immunofluorescence was performed as 
described earlier with modifications to the protocol following incubation with secondary 
antibodies. After secondary antibodies cells were washed 3 times in PBS at RT and then 
fixed with 4% PFA in PBS for 20 mins and washed three times with PBS. Cells were 
incubated in 70% ethanol, 85% ethanol and then 100% ethanol for 1 min at RT. Probe 
hybridization mixture was made with 7µl of FISH Hybridization Buffer (Agilent G9400A), 
1 µl of FISH probes and 2µl of water. 5µl of mixture was added on a slide and coverslip was 
placed on top. Coverslip was sealed using rubber cement. Once rubber cement solidified 
genomic DNA and probes were denatured at 78C for 5 mins and slides were incubated at 
Zamudio et al. Page 12
Mol Cell. Author manuscript; available in PMC 2020 December 05.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
16C in the dark overnight. Coverslips were removed from the slide and incubated in a pre-
warmed Wash Buffer 1 at 73C for 3 mins and in Wash Buffer 2 for 1 min at RT. Slides were 
air dried and nuclei stained with Hoechst in PBS for 5 mins at RT. Coverslips were washed 
three times in PBS, mounted on a slide using Vectashield H-1000 and sealed with nail 
polish. Images were acquired using an RPI Spinning DIsk confocal microscope with a 100x 
objective using the MetaMorph acquisition software and a Hammamatsu ORCA-ER CCD 
Camera. DNA FISH probes were custom designed and generated by Agilent to target the 
Nanog locus.
Co-Immunofluorescence with RNA FISH: Immunofluorescence was performed as 
previously described (Sabari et al., 2018) with the small modifications. Immunofluorescence 
was performed in a RNase-free environment, pipettes and bench were treated with 
RNaseZap (Life Technologies, AM9780). RNase free PBS was used and antibodies were 
diluted in RNase-free PBS at all times. After immunofluorescence completion. Cells were 
post-fixed with 4% PFA in PBS for 10 min at RT. Cells were washed twice with RNase-free 
PBS. Cells were washed once with 20% Stellaris RNA FISH Wash Buffer A (Biosearch 
Technologies, Inc., SMF-WA1–60), 10% Deionized Formamide (EMD Millipore, S4117) in 
RNase-free water (Life Technologies, AM9932) for 5 min at RT. Cells were hybridized with 
90% Stellaris RNA FISH Hybridization Buffer (Biosearch Technologies, SMF-HB1–10), 
10% Deionized Formamide, 12.5 µM Stellaris RNA FISH probes designed to hybridize 
introns of the transcripts of SE-associated genes. Hybridization was performed overnight at 
37°C. Cells were then washed with Wash Buffer A for 30 min at 37°C a nd nuclei were 
stained with 20µm/ml HOESCHT in Wash Buffer A for 5 min at RT. After one 5-min was 
with Stellaris RNA FISH Wash Buffer B (Biosearch Technologies, SMF-WB1–20) at room 
temperature. Coverslips were mounted as described for immunofluorescence. Images were 
acquired at the RPI Spinning Disk confocal microscope with 100x objective using 
MetaMorph acquisition software and a Hammamatsu ORCA-ER CCD camera. Primary 
antibodies used were anti-MED1 Abcam ab64965 1:500 dilution, anti-b catenin Abcam 
ab22656 1:500 dilution, anti-pSTAT3 Santa Cruz 1:20 dilution, anti-SMAD2/3 Santa Cruz 
1:20 dilution). Secondary antibodies used were anti-Rabbit IgG, anti-goat IgG and anti-
mouse IgG.
Protein purification: cDNA encoding the genes of interest or their IDRs were cloned into a 
modified version of a T7 pET expression vector. The base vector was engineered to include 
a 5’ 6xHIS followed by either mEGFP or mCherry and a 14 amino acid linker sequence 
“GAPGSAGSAAGGSG.” NEBuilder® HiFi DNA Assembly Master Mix (NEB E2621S) 
was used to insert these sequences (generated by PCR) in-frame with the linker amino acids. 
Vectors expressing mEGFP or mCherry alone contain the linker sequence followed by a 
STOP codon. Mutant sequences were synthesized as geneblocks (IDT) and inserted into the 
same base vector as described above. All expression constructs were sequenced to ensure 
sequence identity.
For protein expression plasmids were transformed into LOBSTR cells (gift of Chessman 
Lab) and grown as follows. A fresh bacterial colony was inoculated into LB media 
containing kanamycin and chloramphenicol and grown overnight at 37oC. Cells containing 
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the MED1-IDR constructs were diluted 1:30 in 500ml room temperature LB with freshly 
added kanamycin and chloramphenicol and grown 1.5 hours at 16oC. IPTG was added to 
1mM and growth continued for 18 hours. Cells were collected and stored frozen at −80oC. 
Cells containing all other constructs were treated in a similar manner except they were 
grown for 5 hours at 37 oC after IPTG induction. The 2X IDR β-catenin protein was 
expressed in Baculovirus infected Sf9 cells. Bacmid transfections were performed using 
Cellfectin II reagent (Thermo 10362100) per manufacturer recommendations.
Pellets of 500ml of Beta Catenin mutant cells were resuspended in 15ml of denaturing buffer 
(50mM Tris 7.5, 300mM NaCl, 10mM imidazole, 8M Urea) containing cOmplete protease 
inhibitors (Roche, 11873580001) and sonicated (ten cycles of 15 seconds on, 60 sec off). 
The lysates were cleared by centrifugation at 12,000g for 30 minutes and added to 1ml of 
pre-equilibrated Ni-NTA agarose (Invitrogen, R901–15). Tubes containing this agarose 
lysate slurry were rotated for 1.5 hours at room temperature. The slurry was centrifuged at 
3,000 rpm for 10 minutes in a Thermo Legend XTR swinging bucket rotor. The pellets were 
washed 2 X with 5ml of lysis buffer followed by centrifugation 10 minutes at 3,000 rpm as 
above. Protein was eluted 3 X with 2ml of the lysis buffer with 250mM imidazole. For each 
cycle the elution buffer was added and rotated at least 10 minutes and centrifuged as above. 
Eluates were analyzed on a 12% acrylamide gel stained with Coomassie. Fractions 
containing protein of the expected size were pooled, diluted 1:1 with the 250mM imidazole 
buffer and dialyzed first against buffer containing 50mM Tris pH 7.5, 125Mm NaCl, 1mM 
DTT and 4M Urea, followed by the same buffer containing 2M Urea and lastly 2 changes of 
buffer with 10% Glycerol, no Urea. Any precipitate after dialysis was removed by 
centrifugation at 3.000rpm for 10 minutes. MED1-IDR, WT Beta Catenin and 2X IDR Beta 
Catenin were purified in a similar manner except the lysis buffer contained no urea, the 
incubations were done at 4C and dialysis was into 2 changes of 50mM Tris pH7.5, 125mM 
NaCl, 10% glycerol and 1mM DTT.
In vitro droplet formation assay: Recombinant GFP or mCherry fusion proteins were 
concentrated and desalted to an appropriate protein concentration and 125mM NaCl using 
Amicon Ultra centrifugal filters (30K MWCO, Millipore). Recombinant proteins were added 
to solutions at varying concentrations with indicated final salt and 10% PEG-8000 as 
crowding agent in Droplet Formation Buffer (50mM Tris-HCl pH 7.5, 10% glycerol, 1mM 
DTT). The protein solution was immediately loaded onto a homemade chamber comprising 
a glass slide with a coverslip attached by two parallel strips of double-sided tape. Slides 
were then imaged with an Andor confocal microscope with a 150x magnification. Unless 
indicated, images presented are of droplets settled on the glass coverslip. Coverslips were 
coated with PEG-silane in order to neutralize charge. In brief, coverslips were washed with 
2% Helmanex III for 2 hours, washed with H2O three times and washed with ethanol once 
before being incubated in 0.5% PEG-silane in ethanol with 1% Acetic Acid over night. They 
were then washed with ethanol once and sonicated in a water bath sonicator for 15 minutes 
in ethanol, washed with H2O for three times before being rinsed with ethanol and dried to 
the air.
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Droplet Assays in Nuclear Extract: Coding sequence of desired genes were cloned into a 
mammalian expression vector (modified from Addgene #32104) containing either mEGFP 
or mcherry. These vectors were transfected into 20 × 106 HEK293T cells using PEI 
transfection reagent (Polysciences Catalog# 23966). 48 hr post transfection, cells were 
resuspended in 10 ml HMSD50 buffer (20mM HEPES, 5mM MgCl2 250mM sucrose, 1mM 
DTT, 50mM NaCl supplemented with 0.2 mM PMSF and 5 mM sodium butyrate) and 
incubated for 30 min at 4° C with gentle agitation. The solution was spun down at 3500 rpm 
at 4° C for 10 min. The supernatant was discarded and the pellet containing nuclei were 
washed in Mnase buffer (20mM HEPES, 100mM NaCl, 5mM MgCl2, 5mM CaCl2, 
protease and phosphatase inhibitors). The washed nuclei were resuspended in one pellet 
volume of Mnase buffer and treated with 1u Mnase (Sigma #N3755) at 37° C for 10 min. 
One pellet volume of stop buffer (20mM HEPES, 500mM NaCl, 5mM MgCl2, 30% 
glycerol, 15mM EGTA, protease and phosphatase inhibitors) was added to stop the reaction. 
The solution was briefly sonicated and spun down at 3500 rpm at 4° C for 10 min. The 
supernatant was spun down again at 3500 rpm at 4° C for 5 min to clear the nuclear extract. 
The nuclear extract (~10 mg/ml) was used for droplet formation assays. The concentrations 
of the overexpressed proteins within nuclear extracts were measured by dot blot using 
recombinant mEGFP or mcherry as standard: mEGFP or GFP tagged B-catenin: 5 µM; 
mEGFP: 25 µM; mcherry: 40 µM; MECP2: 20 µM; MED12: 5 µM. Droplet formation was 
induced by 1:1 dilution of the nuclear extract with Buffer B (10% glycerol, 20mM HEPES). 
The final droplet buffer conditions were 20mM HEPES, 150mM NaCl, 15% glycerol, 
3.75mM EGTA, 2.5mM MgCl2, 1.25mM CaCl2. The reactions were incubated for 30 min 
in 8-well PCR strips and loaded onto glass bottom 384 well plate (Cellvis P384–1.5H-N) 5 
min prior to imaging on an Andor confocal microscope at 150X magnification.
Purification of Mediator: Mediator samples were purified as previously described (Meyer 
et al. 2008, doi:10.1038/emboj.2008.78) with modifications. The P0.5M/QFT fraction was 
concentrated, to 12 mg/mL, by ammonium sulfate precipitation (35%). The resulting pellet 
was resuspended in pH 7.9 buffer containing 20 mM KCl, 20 mM HEPES, 0.1 mM EDTA, 2 
mM MgCl2, 20% glycerol and dialyzed against pH 7.9 buffer containing 0.15 M KCl, 20 
mM HEPES, 0.1 mM EDTA, 20% glycerol, and 0.02% NP-40 prior to the affinity 
purification step. Affinity purification was carried out as described (Meyer et al. 2008, doi:
10.1038/emboj.2008.78).
RT-qPCR: RNA was isolated using the Rneasy Plus Mini Kit (QIAGEN, 74136) according 
to manufacturer’s instructions. cDNA was generated using SuperScript II Reverse 
Transcriptase (Invitrogen, 18080093) with oligo-dT primers (Promega, C1101) according to 
manufacturer’s instructions. Quantitative real-time PCR was performed on Applied 
Biosystems 7000, QuantStudio5 and QuantStudio6 instruments using TaqMan probes for SE 
genes.
ChIP: Cells were plated at a density of 4–5 million cells per plate and harvested 24–48 
hours after. 1% formaldehyde in PBS was used for crosslinking of cells for 15 minutes, 
followed by quenching with Glycine at a final concentration of 125mM on ice. Cells were 
washed with cold PBS and harvested by scraping cells in cold PBS. Collected cells were 
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pelleted at 1500 g for 5 minutes at 4°C, resuspended in LB1 (50mM Hepes- KOH, pH7.9, 14 
0mM NaCl, 1mM EDTA 0.5mL 0.5M, 10% glycerol, 0.5% NP40, 1% TritonX-100, 1x 
protease inhibitor) and incubate for 20 minutes rotating at 4°C. Cells were pelleted for 5 
minutes at 1350 g, resuspended in LB2 (10 mM Tris pH 8.0, 200 mM NaCl, 1 mM EDTA, 
0.5 mM EGTA, 1x protease inhibitor) and incubated for 5 minutes rotating at 4°C. Pellet 
was resuspended in LB3 (10 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 
0.1% sodium-deoxycholate, 0.5% sodium lauroyl sarcosinate, 1% TritonX-100, 1x protease 
inhibitor) at a concentration of 30–50 million cells/ml. Cells were sonicated using Covaris 
S220 for 12 minutes using the manufacturer’s instructions followed by spinning at 20 000g 
for 30 minutes at 4°C. Dynabead s pre-blocked with 0.5% BSA were incubated with GFP 
antibody (Abcam, ab290), Med1 antibody (Abcam, ab64965) or dsRed (Takara, 632496) 
antibody for 6 hours. Chromatin was added to antibody-bead complex and incubated 
rotating overnight at 4°C. Beads were was hed three times with each Wash buffer 1 (50mM 
Hepes pH7.5, 500mM NaCl, 1mM EDTA, 1mM EGTA,1% Triton, 0.1% NaDoc, 0.1% SDS) 
and Wash Buffer 2 (20mM Tris pH 8, 1mM EDTA, 250mM LiCl, 0.5% NP40, 0.5% NaDoc) 
at 4°C, followed by washing one time with TE at roo m temperature. Chromatin was eluted 
by adding Elution buffer (50 mM, Tris pH 8.0, 10 mM EDTA, 1% sodium dodecyl sulfate, 
20ug/ml RNaseA) to the beads and incubated shaking at 60°C for 30 minutes. Reversal of 
crosslinking was performed for 4 hours at 58°C. Proteinase K was added and incubated for 
1–2 hours at 37°C for protein removal. DNA was purified using Qi agen PCR purification 
kit and resuspended in 10mM Tris-HCL. ChIP Libraries were prepared with the Swift 
Biosciences Accel-NGS® 2S Plus DNA Library Kit according to kit instructions with an 
additional size selection step on the PippinHT system from Sage Science. Following library 
prep, ChIP libraries were run on a 2% gel on the PippinHT with a size collection window of 
200–600 bases. Final libraries were quantified by qPCR with the KAPA Library 
Quantification kit from Roche and sequenced in single-read mode for 40 bases on an 
Illumina HiSeq 2500.
QUANTIFICATION AND STATISTICAL ANALYSIS
FRAP quantification—Fluorescence intensity was measured using FIJI. Background 
intensity was subtracted and values are reported relative to pre-bleaching time points.
Custom MATLAB™ scripts were written to process the intensity data, accounting for 
background photobleaching and normalization to pre-bleach intensity. Post bleach FRAP 
recovery data was averaged over 9 replicates for each cell-line and condition. The FRAP 
recovery curve was fit to:
FRAP t = M(1 − exp − tτ )
Average image analysis—For analysis of RNA FISH with immunofluorescence, custom 
MATLAB™ scripts were written to process and analyze 3D image data gathered in RNA 
FISH and IF channels. FISH foci were identified in individual z-stacks through intensity and 
size thresholds, centered along a box of size l = 2.9 µm and stitched together in 3-D across z-
stacks. For every FISH focus identified, signal from the corresponding location in the IF 
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channel is gathered in the l x l square centered at the RNA FISH focus at every 
corresponding z-slice. The IF signal centered at FISH foci for each FISH and IF pair are 
then combined and an average intensity projection is calculated, providing averaged data for 
IF signal intensity within a l x l square centered at FISH foci. The same process was carried 
out for the FISH signal intensity centered on its own coordinates, providing averaged data 
for FISH signal intensity within a l x l square centered at FISH foci. As a control, this same 
process was carried out for IF signal centered at randomly selected nuclear positions. For 
each replicate, 40 random nuclear points were generated from the interior of the nuclear 
envelope, identified from the DAPI channel by a combination of large size (200 voxels) and 
intensity (DNA dense) thresholds. These average intensity projections were then used to 
generate 2D contour maps of the signal intensity. Contour plots are generated using built-in 
functions in MATLAB™. For the contour plots, the intensity-color ranges presented were 
customized across a linear range of colors (n! = 15). For the FISH channel, black to magenta 
was used. For the IF channel, we used chroma.js (an online color generator) to generate 
colors across 15 bins, with the key transition colors chosen as black, blueviolet, 
mediumblue, lime. This was done to ensure that the reader’s eye could more readily detect 
the contrast in signal. The generated colormap was employed to 15 evenly spaced intensity 
bins for all IF plots. The averaged IF centered at FISH or at randomly selected nuclear 
locations are plotted using the same color scale, set to include the minimum and maximum 
signal from each plot.
Heterotypic droplet analysis—To analyze in vitro droplet experiments, custom Python 
scripts using the scikit-image package were written to identify droplets and characterize 
their size, shape, and intensity. Droplets were segmented from average images of captured 
channels on various criteria: (1) an intensity threshold three standard deviations above the 
mean of the image, (2) size thresholds (9 pixel minimum droplet size), (3) and a minimum 
circularity (circularity = 4   π * area
perimiter2
) of 0.8 (1 being a perfect circle). After segmentation, 
mean intensity for each droplet was calculated while excluding pixels near the phase 
interface (Banani et al., 2016). Hundreds of droplets identified in typically 5–10 independent 
fields of view were quantified. The mean intensity within the droplets (C-in) and in the bulk 
(C-out) were calculated for each channel. The partition ratio was computed as (C-in)/(C-
out). The box plots show the distributions of all droplets. The measured datasets for partition 
ratio versus the protein concentration in Figure 2b were fitted by the logistic equation (Wang 
et al., 2018):
f = a
1 + e
− x − x0b
Where f is the partition ratio and x is the corresponding protein concentration.
ChIP-seq analysis—ChIP-Seq data were aligned to the mm9 version of the mouse 
reference genome using bowtie with parameters –k 1 –m 1 –best and –l set to read length. 
Wiggle files for display of read coverage in bins were created using MACS with parameters 
–w –S space=50 –nomodel –shiftsize=200, and read counts per bin were normalized to the 
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millions of mapped reads used to make the wiggle file (Zhang et al., 2008). Reads-per-
million normalized wiggle files were displayed in the UCSC genome browser (Kent et al., 
2002)
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HIGHLIGHTS
• Signaling factors incorporate into Mediator condensates at super-enhancers
• β-catenin IDRs are required for both phase separation and target gene 
activation
• Both condensate interactions and TF interactions contribute to β-catenin 
localization
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Figure 1. Signaling factors form signaling dependent condensates at super-enhancers in vivo
1A) Immunofluorescence for β-catenin, STAT3, SMAD3 and MED1 with concurrent RNA-
FISH for Nanog nascent RNA demonstrating the presence of condensed nuclear foci of the 
signaling factors at the Nanog super-enhancer in mES cells. Cells were grown for 24 hours 
in the presence of CHIR99021, LIF and Activin A to activate the WNT, JAK/STAT and 
TGF-β signaling pathways respectively 24 hours prior to fixation. Hoechst staining was used 
to determine the nuclear periphery, highlighted with a dotted line.100x objective was used 
for imaging on a spinning disk confocal microscope. Average RNA-FISH signal and average 
IF signal centered on the RNA-FISH focus for each signaling factor from at least 10 images 
is shown. Average signaling factor IF signal around randomly selected nuclear positions is 
displayed in the right most panel. Scale bars indicate 5 µm.
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1B) ChIP-seq tracks displaying occupancy of β-catenin, STAT3, SMAD3 and MED1 in 
mES at the super-enhancer associated with the Nanog gene. Read densities are displayed in 
reads per million per bin (rpm/bin) and the super-enhancer is indicated with a red bar.
1C) Immunofluorescence of mES cells for the signaling factors β-catenin, STAT3 and 
SMAD3 in unstimulated or stimulated conditions. Cells were stimulated for 24 hours with 
either CHIR99021, LIF, or Activin A to activate the WNT, JAK/STAT and TGF-β signaling 
pathways respectively 24 hours prior to fixation. Hoechst staining was used to determine the 
nuclear periphery, highlighted with a dotted line.100x objective was used for imaging on a 
spinning disk confocal microscope. Scale bars indicate 5 µm.
1D) Top left: Representative images of FRAP experiment of mEGFP-β-catenin engineered 
HCT116 cells. Yellow box highlights the punctum undergoing targeted bleaching. Top right: 
Quantification of FRAP data for mEGFP-β-catenin puncta. Bottom left: Representative 
images of FRAP experiment of mEGFP-HP1α engineered HCT116 cells. Yellow box 
highlights region undergoing targeted bleaching. Bottom right: Quantification of FRAP data 
for mEGFP-HP1α puncta. Bleaching event occurs at t = 0s. For both bleached area and 
unbleached control, background-subtracted fluorescence intensities are plotted relative to a 
pre-bleach time point (t = −4s). Data are plotted as mean +/− SEM (N=9). Images were 
taken using the Zeiss LSM 880 confocal microscope with Airyscan detector with a 63x 
objective. Scale bar indicates 2 µm. 1E) Live cell imaging of endogenously-tagged mEGFP-
β-catenin in HEK293T cells stimulated with CHIR99021 and imaged over time. 
Representative images of cells imaged over a four hour time course in the top panels. 
Identified foci used for quantification in the bottom panels. Foci in the nucleus were called 
and quantified at different time intervals for three biological replicates (right panel). Images 
were acquired using a Zeiss LSM 880 confocal microscope with Airyscan detector and a 
63x objective. Scale bar indicates Scale bar indicates 2 µm.
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Figure 2. Purified signaling factors can form condensates in vitro
2A) Domain structures of the signaling factors used in this manuscript. DBD: DNA binding 
domain, PID: protein interaction domain, CC: coiled coil domain, DD: dimerization domain, 
SH2: Src homology domain 2. The predicted intrinsically disordered regions (IDR) are 
indicated with red brackets.
2B) Representative confocal images of concentration series of droplet formation assay 
testing homotypic droplet formation of mEGFP-β-catenin, mEGFP-STAT3 and mEGFP-
SMAD3. mEGFP alone is included as a control (left panels). Quantification of the partition 
ratio for the signaling factors (right panels). Partition ratio was calculated by dividing the 
average fluorescence signal inside the droplets by the average fluorescence signal outside the 
droplets for at least 10 acquired images at all concentrations tested. All assays were 
performed in the presence of 125mM NaCl and 10% PEG-8000 was used as a crowding 
agent. Scale bars indicate 2 µm.
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2C) Dilution droplet assay for the signaling factors. Initial droplets were formed at 1.25µM 
and imaged. The remaining reaction mixture was then diluted 2-fold with reaction buffer 
containing 4M NaCl to obtain a final salt concentration of 2M NaCl. Representative images 
of droplets before and after dilution are displayed.
2D) Representative images of FRAP of in vitro droplets of mEGFP-fused β-catenin, STAT3 
and SMAD3 showing recovery after photobleaching in the order of seconds. Droplet 
formation assays were performed in the presence of 125 mM NaCl and 10% PEG-8000. 
Scale bars indicate 2 µm. FRAP was performed with a spinning disk confocal miscroscope 
using a 150x objective.
2E) Signaling factors form droplets in the presence of nuclear extracts. HEK293T cells were 
transfected with β-catenin, STAT3 or SMAD3 and nuclear extracts imaged using a spinning 
disk confocal microscope with a 150x objective. Scale bar indicates 2 µm.
2F) Phase diagrams for β-catenin, STAT3 or SMAD3 showing concentrations of salt and 
protein in which factors separate into a light and a dense phase (black dots) and conditions 
in which only a light phase is present (white dots). Droplet formation assays were performed 
in the presence of 5% PEG-8000 at the concentrations depicted in the diagram. Droplets 
were imaged with a spinning disk confocal miscroscope with a 150x objective. Partition 
ratio was calculated for 10 images and proteins assessed to be in a one or two phase regime 
by comparing the partition ratio to that of a mEGFP control.
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Figure 3. Purified signaling factors are incorporated into Mediator condensates in vitro
3A) Schematic representation of addition of signaling factor to pre-existing MED1-IDR 
droplets. mCherry-MED1-IDR droplets were formed and placed in a glass dish and imaged 
before and after addition of mEGFP-tagged signaling factors.
3B) Representative images of signaling factor incorporation into MED-IDR droplets. 
Preformed mCherry-MED1-IDR droplets were imaged pre and post addition of mEGFP-
tagged signaling factor solution for a total of 10 mins. Signaling factor was added 30 sec 
after imaging acquisition started. Last image displayed corresponds to the imaging end 
point. 10µM of MED1-IDR-mCherry in the presence of PEG-8000 was used for droplet 
formation and 10uM of either mEGFP-β-catenin, mEGFP-SMAD3 or mEGFP-STAT3 in the 
absence of PEG-8000 was added. Scale bars indicate 2 µm.
3C) Partition ratio was calculated for pre-formed MED1-IDR-mCherry droplets that were 
mixed with dilute GFP-tagged signaling factor using the same conditions as in B. At least 10 
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images were used for quantification. Droplets were called on merged channels and signal 
intensity for the GFP-tagged factor in the area within the droplet compared to the intensity 
of the area outside of the droplet. Star indicates p-value obtained by a t-test < 0.05.
3D) Representative images of in vitro droplet assays of signaling factors with purified 
Mediator showing the ability of β-catenin, STAT3 and SMAD3 to interact and partition into 
intact Mediator droplets. Reactions were performed in the presence of 10% PEG-8000 and 
300 nM signaling factor and imaged using a spinning disk confocal microscope with a 150x 
objective. Scale bars indicate 2 µm.
3E) Limited dilution droplet assay with near physiological concentrations of β-catenin, 
STAT3 and SMAD3. Indicated concentrations of the signaling factors were either added to 
droplet formation buffer alone (125mM NaCL and 10% PEG-8000) or in combination with 
10 µM MED1-IDR. Scale bars indicate 2 µm.
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Figure 4. Phase separation of β-catenin is dependent on its IDRs
4A) Left: Diagram of the different forms of mEGFP-β-catenin proteins tested. Right: 
Representative confocal images of a concentration series of droplet formation assays testing 
homotypic droplet formation for mEGFP, mEGFP-β-catenin, mEGFP-N-terminal-IDR, 
mEGFP-Armadillo, mEGFP-C-terminal-IDR, mEGFP-chimera, mEGFP-2xIDR, mEGFP-
full-length aromatic mutant, and mEGFP-chimera-aromatic mutant. Droplet assays were 
performed in 125mM NaCL and 10% PEG-8000. Scale bar indicates 1um.
4B) Representative confocal images of heterotypic droplet formation assays mixing 10 µM 
MED1-IDR-mCherry with 10µM of wild type full length mEGFP-β-catenin or full length 
aromatic mutant mEGFP-β-catenin. Scale bar indicates 1 µm.
4C) Partition ratio of factors was quantified for at least 10 images each. Droplets were called 
on merged channels and signal intensity for the factor in the area within the droplet 
compared to the intensity of the area outside the droplet.
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Figure 5. Addressing of β-catenin and activation of target genes is dependent on its IDRs
5A) Schematic of the ChIP experiment. TdTomato-tagged wild type or aromatic mutant β-
catenin were stably integrated in mES cells under a doxycycline-inducible promoter. 
Doxycycline and an inhibitor of the WNT pathway was added to the media 24 hours prior to 
crosslinking. ChIP was performed using antibodies against TdTomato. TRE = Tetracycline 
responsive element.
5B) ChIP-qPCR of ectopically-expressed wild type and aromatic mutant β-catenin at Myc, 
Sp5, and Klf4 enhancers. Error bars indicate standard deviation of three replicates. Stars 
indicate p-values obtained by a t-test < 0.05.
5C) RT-qPCR of mRNA levels after ectopic expression of wild type or aromatic mutant β-
catenin of Myc, Sp5, and Klf4. Error bars indicate standard deviation of three replicates. 
Stars indicate p-values obtained by a t-test < 0.05.
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5D) Luciferase assay using a synthetic WNT-reporter containing 10 copies of the consensus 
TCF/LEF motif where wild type or aromatic mutant was overexpressed in HEK293T cells. 
Average of 3 biological replicates is shown. Error bars show the standard deviation. Star 
indicates p-value obtained by a t-test < 0.05.
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Figure 6. β-catenin-condensate interaction can occur independent of TCF factors
6A) Immunofluorescence of β-catenin in Lac-U2OS cells transfected with a Lac binding 
domain-CFP or a Lac binding domain-CFP-MED1-IDR construct, imaged with a 100x 
objective on a spinning disk confocal microscope. Hoechst staining was used to determine 
the nuclear periphery, highlighted with a dotted line. Quantification shows the relative 
intensity of β-catenin in CFP foci. Scale bar indicates 5µm.
6B) Fluorescence imaging of overexpressed TdTomato-tagged wild type or aromatic mutant 
β-catenin in U2OS 2–6-3 cells co-transfected with a Lac binding domain-CFP or a Lac 
binding domain-CFP-MED1-IDR construct, imaged with a 100x objective on a spinning 
disk confocal microscope. Hoechst staining was used to determine the nuclear periphery, 
highlighted with a dotted line. Quantification shows the relative intensity of over-expressed 
β-catenin forms in called CFP foci. Scale bar indicates 5µm.
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6C) ChIP-qPCR for β-catenin-GFP-chimera and chimera mutant at the enhancers of SOX9, 
SMAD7 and KLF9 in HEK293T cells. Error bars show the standard deviation of the mean. 
Stars indicate p-values obtained by a t-test < 0.05
6D) Luciferase assay of cells over-expressing β-catenin-mEGFP-chimera or mutant chimera 
in combination with a synthetic WNT-reporter containing 10 copies of the consensus 
TCF/LEF motif. Average of 3 biological replicates is shown. Untransfected control and WT 
FL-β-catenin came from the same experiment and are the same as in Figure 5, but displayed 
in two different graphs. Error bars show the standard deviation. Stars indicate p-values 
obtained by a t-test < 0.05.
Zamudio et al. Page 33
Mol Cell. Author manuscript; available in PMC 2020 December 05.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 7. Both IDRs and Armadillo domains enable selective occupancy of super-enhancer genes
7A) Cartoon depicting the different forms of β-catenin used in ChIP-seq experiments.
7B) ChIP-sequencing tracks of Nanog and mir290 showing binding of β-catenin-armadillo 
repeats and IDRs to super-enhancer associated genes. Read densities are displayed in reads 
per million per bin (rpm/bin) and the super-enhancer is indicated with a red bar.
C) Quantification of ChIP-seq read densities of super-enhancers (SE) and typical enhancers 
(TE) of the different forms of β-catenin.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
GFP Abcam ab290
Med1 Abcam ab64965
β-catenin Abcam ab22656
STAT3 Santa Cruz SC-7993
SMAD3 Santa Cruz SC-6202
TCF7L2 Santa Cruz Sc8631
TCF1/TCF7 Cell Signaling 2203
TCF3/TCF7L1 Cell Signaling 2883
LEF1 Cell Signaling 2230
DsRed Takara 632496
Chemicals, Peptides, and Recombinant Proteins
mEGFP This study N/A
mEGFP-β-catenin This study N/A
mEGFP-STAT3 This study N/A
mEGFP-SMAD3 This study N/A
mCherry-MED1-IDR This study N/A
mEGFP-β-catenin-N-terminus This study N/A
mEGFP-β-catenin-Armadillo This study N/A
mEGFP-β-catenin-C-terminus This study N/A
mEGFP-β-catenin-Aromatic-Mutant This study N/A
mEGFP- β-catenin-chimera This study N/A
mEGFP-β-catenin-chimera-mutant This study N/A
mEGFP-β-catenin-2XIDR This study N/A
Full Mediator This study N/A
CHIR99021 Stemgent 04–0004
Leukemia Inhibitory Factor (LIF) ESGRO ESG1107
Activin A R&D systems 338-AC-010
IWP2 Sigma Aldrich I0536
SB431542 Tocris Bioscience 16–141
Critical Commercial Assays
Dual-glo Luciferase Assay System Promega E2920
NEBuilder HiFi DNA Assembly Master Mix NEB E2621S
Power SYBR Green mix Life Technologies 4367659
TaqMan Universal PCR Master Mix Applied Biosystems 4304437
RNeasy Plus Mini Kit QIAGEN 74136
Sp5 probe Taqman® Mm00491634_m1
Mol Cell. Author manuscript; available in PMC 2020 December 05.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Zamudio et al. Page 36
REAGENT or RESOURCE SOURCE IDENTIFIER
Myc probe Taqman® Mm00487804_m1
Gapdh probe Taqman® Mm99999915_g1
Deposited Data
Med1 ChIP-seq This study GSE134387
GFP-β-catenin ChIP-seq This study GSE134387
GFP-armadillo ChIP-seq This study GSE134387
GFP-chimera ChIP-seq This study GSE134387
Imaging data This study http://dx.doi.org/10.17632/x4j73×87bj.1
Imaging data This study http://dx.doi.org/10.17632/99bt56v4zs.1
Experimental Models: Cell Lines
V6.5 cells Rudolf Jaenisch N/A
β-catenin-GFP-tagged V6.5 cells This study N/A
β-catenin-GFP-tagged HCT116 cells This study N/A
Hp1α-GFP-tagged HCT116 cells This study N/A
C2C12 cells ATCC N/A
HEK293T cells ATCC N/A
TdTomato-wild-type-β-catenin V6.5 cells This study N/A
TdTomato-aromatic-mutant-β-catenin V6.5 cells This study N/A
U2OS-2–6-3 cells Spektor Lab N/A
GFP-chimera HEK293T cells This study N/A
GFP-chimera-mutant HEK293T cells This study N/A
GFP-armadillo V6.5 cells This study N/A
GFP-chimera V6.5 cells This study N/A
Oligonucleotides
Oligonucleotides used in this study are listed in Table S1 This study N/A
Recombinant DNA
pJM101-PiggyBac-BetaCat-FL This study N/A
pJM102-PiggyBac-BetaCat-AromaticMut This study N/A
pJS-21-mEGFP-Bcat-repair-mo This study N/A
pJS-22-mEGFP-Bcat-repair-hu This study N/A
pX330-GFP-B-catenin This study N/A
Software and Algorithms
Fiji image processing package Schindelin et al., 2012 https://fiji.sc/
MetaMorph acquisition software Molecular Devices https://www.moleculardevices.com/products/cellular-
imaging-systems/acquisition-and-analysis-software/
metamorph-microscopy
PONDR http://www.pondr.com/ N/A
MACS Zhang et al., 2008 N/A
Bowtie Langmead et al., 2009 N/A
Other
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REAGENT or RESOURCE SOURCE IDENTIFIER
Nanog RNA FISH probe Stellaris N/A
miR290 RNA FISH probe Stellaris N/A
Nanog DNA FISH probe Agilent N/A
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